Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Exosomal protein CD82 as a diagnostic biomarker for precision medicine for breast cancer

3 Jan 2019

Abstract excerpt

CD82, a member of the tetraspanin superfamily, has been proposed to exert its activity via tetra-transmembrane protein enriched microdomains (TEMs) in exosomes. The present study aimed to explore the potential of the exosome protein CD82 in diagnosing breast cancers of all stages and various histological subtypes in patients. The results strongly suggest that CD82 expression in breast cancer tissue was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Extracellular vesicles in disease
Share to MicroRNA in disease regulation
Share to Viral Infections and Vectors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30604894
DOI: 10.1002/mc.22960

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Exosomal protein CD82 as a diagnostic biomarker for precision medicine for breast cancerPMID 30604894Read ↗

Identification of an exosome-related signature associated with prognosis and immune infiltration in breast cancerSemantic proximity Read ↗

Early Detection and Investigation of Extracellular Vesicles Biomarkers in Breast CancerSemantic proximity Read ↗

From Cell Lines to Patients: Dissecting the Proteomic Landscape of Exosomes at Breast CancerSemantic proximity Read ↗

Evaluation of miRNA-21-5p and miRNA-10b-5p levels in serum-derived exosomes of breast cancer patients in different gradesSemantic proximity Read ↗

CD81 partners with CD44 in promoting exosome biogenesis, tumor cluster formation, and lung metastasis in triple negative breast cancerSemantic proximity Read ↗

Tetraspanins in human epithelial malignanciesSemantic proximity Read ↗

Evaluation of the Ultrastructure and Expression of Desmoglein 2 in Breast Cancer: A Novel BiomarkerSemantic proximity Read ↗

Proteomic Landscape of Exosomes Reveals the Functional Contributions of CD151 in Triple-Negative Breast CancerSemantic proximity Read ↗

MRPS28 serves as a biomarker of diagnostic, prognostic, and immune modulation in pan-cancer and promotes breast cancer malignant phenotypes.Semantic proximity Read ↗

CD82 palmitoylation site mutations at Cys5+Cys74 affect EGFR internalization and metabolism through recycling pathway.Semantic proximity Read ↗

Exosomal hsa-miR-21-5p is a biomarker for breast cancer diagnosisSemantic proximity Read ↗

UTP23 is a promising prognostic biomarker and is associated with immune infiltration in breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.